Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

FIVE at FIVE AU: Fed widely expected to relax monetary policy as ASX rises

Published 13/12/2023, 04:03 pm
© Reuters.  FIVE at FIVE AU: Fed widely expected to relax monetary policy as ASX rises

The ASX 200 was up today, gaining 23.80 points or 0.33% to 7,259.10 and setting a new 50-day high.

Over the last five days, the index has gained 1.24% and is currently 3.97% off its 52-week high.

Health Care was the sector that led the charge, up 1.32%, buoyed by strong performer Neuren Pharmaceuticals Ltd, which was up 7.02%. Materials (0.22%) and Real Estate (0.77%) were also in the green.

On the other side of the ledger were Energy stocks, down 0.75%, and Communication Services, slipping 0.41%.

The good showing here followed positivity on Wall Street after Treasury secretary Janet Yellen said yesterday that in her opinion inflation was ‘meaningfully’ off the boil, and that now it was less of a concern she expected that the job of easing pricing pressures was almost at an end.

"I see no reason, on the path that we're currently on, why inflation shouldn't gradually decline to levels consistent" with the Federal Reserve's 2% target, Yellen said at the Wall Street Journal's CEO Council Summit. The economy continues to operate a "roughly full employment," she said.

IG analyst Tony Sycamore had these observations to make:

“US stock markets closed higher overnight following an inline inflation report ahead of tomorrow's Fed meeting.

"Within the details of the inflation report, headline inflation rose by 0.1% MoM (slightly higher than the 0% expected), still allowing the annual rate to ease to 3.1% from 3.2%. Core inflation rose by 0.3% MoM, which saw the annual rate remain unchanged at 4%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“Attention now turns to tomorrow's Fed meeting. The Fed is expected to keep the Federal Funds target rate unchanged at 5.25%-5.50%.

"As such, interest will focus on whether the statement includes a tightening bias like last month's 'In determining the extent of additional policy firming that may be appropriate to return inflation to 2% over time'. As well as the summary of economic projections (SEP or Dots).

"While it is challenging to assess consensus expectations if the 'dots' show two to three rate cuts in 2024, it will confirm markets remain on the right track, positioning for rate cuts next year.

“Although we remain bullish on the Nasdaq into year-end, we are not contemplating opening fresh longs at these levels. Instead, we would prefer to wait for a corrective pullback and signs of basing as an opportunity to reset longs before a push towards 16,400/500 in the weeks ahead.

“Aware that should the Nasdaq see a sustained break of support at 15,200, it would warn that the rally has run its course and that a deeper pullback is underway towards the 200-day moving average at 14,430.”

The five at five

Syntara doses first patient in bone cancer Phase 2 trial assessing SNT-5505 in combination with ruxolitinib

Syntara Ltd (ASX:SNT), formerly Pharmaxis Ltd, has dosed the first patient in a Phase 2 clinical trial assessing its pan-LOX inhibitor SNT-5505 in combination with kinase inhibitor ruxolitinib in patients with bone marrow cancer myelofibrosis.

Read more

HyTerra delivers maiden independent prospective hydrogen and helium resource estimate in Kansas

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

HyTerra Ltd (ASX:HYT) has unveiled its maiden independent prospective resource estimate for hydrogen and helium within its wholly-owned Project Nemaha leases in Kansas, USA.

Read more

archTIS extends capital funding program; receives more than $2 million in R&D tax incentive

archTIS Ltd is extending its capital funding program through the increased extension of a market rate lending facility with the Commonwealth Bank of Australia for A$2 million.

Read more

Leeuwin Metals’ high-grade lithium assays of up to 4.31% confirm 4.7-kilometre trend at Cross Lake

Results from Leeuwin Metals Ltd's inaugural exploration program at the 100%-owned Cross Lake Lithium Project in Manitoba, Canada, have validated a 4.7-kilometre lithium-caesium-tantalum (LCT) mineralised trend.

Read more

Sunstone Metals raises A$5 million to grow copper-gold discoveries in Ecuador

Sunstone Metals Ltd (ASX:STM) has received firm commitments for A$5.024 million via a share placement at 1.2 cents per share to existing institutional and sophisticated shareholders as well as new investors.

Read more

On your six

Australia’s mid-year outlook reveals improving fiscal position with reduced debt projections

Australia’s Mid Year Economic and Fiscal Outlook (MYEFO) for 2023–24 has revealed an improved fiscal position with lower deficits and reduced gross debt projections compared to the previous budget.

Read more

The one to watch

Kingfisher (LON:KGF) Mining identifies large REE anomalies at LK1

Kingfisher Mining Ltd (ASX:KFM) CEO James Farrell tells Proactive the company has defined several exciting carbonatite targets at the large-scale LK1 rare earth elements (REE) target in the highly prospective Gascoyne Province of Western Australia.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.